אקטיליז 20 מג

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

ALTEPLASE

から入手可能:

BOEHRINGER INGELHEIM ISRAEL LTD.

ATCコード:

B01AD

医薬品形態:

אבקה וממס להכנת תמיסה להזרקה\אינפוזיה

構図:

ALTEPLASE 20 MG/VIAL

投与経路:

תוך-ורידי

処方タイプ:

מרשם נדרש

製:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH, GERMANY

治療群:

ENZYMES

適応症:

Acute Myocardial infarction: Actilyse is indicated for use in the management of acute myocardial infarction (AMI) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infarct size, the improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with AMI. Treatment should be initiated as soon as possible after the onset of AMI symptoms. Massive pulmonary embolism with hemodynamic deprivation : Actilyse is indicated in the management of acute massive pulmonary embolism (PE) in adults : - for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and - for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. The diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. For fibrinolytic treatme

承認日:

2022-06-30